Office of Technology Commercialization

Partners in Innovation: Advancing Georgetown’s breakthroughs for a brighter tomorrow
At Georgetown’s Office of Technology Commercialization, we are driven by a passionate commitment to transforming innovations into impactful solutions.
We are dedicated to propelling GU’s pioneering breakthroughs forward through strategic partnerships and creating new ventures. We are dedicated to bridging the gap between research excellence and real-world application, fostering an environment where entrepreneurship thrives, and ensuring our entire community benefits.
As your partners in innovation and research translation, we engage continuously with knowledgeable and accessible staff, ensuring your ideas make a meaningful impact on society. Welcome to a world of possibilities at the intersection of academia and entrepreneurship!

FY19-23 Commercialization Metrics

$3 MMReveueOngoing growth in tech transfer revenue.
81Issued patents (world-wide)Global patents surge, driving innovation.
$1MMGap fundings awardedInnovative projects funded, bridging gaps.


Featured News

Collaborate. Innovate. Launch: Georgetown’s Inaugural Faculty Entrepreneurship Academy

In the spirit of collaboration and innovation, Georgetown University recently hosted its inaugural Faculty Entrepreneurship Academy. This event, organized by the Office of Technology…

May 6, 2024

Featured News

Inspiring Tomorrow through Innovation and Excellence

Highlights of Georgetown’s 2024 Innovation Awards Ceremony  Georgetown’s Office of Technology Commercialization proudly hosted the 2024 Innovation Awards Ceremony, a testament to the…

March 14, 2024

Featured News

NIH SBIR/STTR Programs Funding Opportunities Learning Session

Georgetown University and George Washington University faculty and staff learned about the National Cancer Institute’s Small Business Innovation Research Development Center Programs. Georgetown’s…

February 7, 2024

Technology Spotlight

Advancing Cancer Therapy: Innovative Predictive Model for CAR-T Treatment Efficacy

Georgetown researchers have developed a cutting-edge method involving tumor biopsies and zebrafish xenografts to assess the potential response to CAR-T cell therapy before treatment initiation.

Learn More

Advancing NeonatalCare: Fibractant – A Synthetic Lung Surfactant for Premature Infants

Georgetown University has pioneered a remarkable synthetic lung surfactant known as “Fibractant.” Composed of silk fibroin and DPPC lipids, this innovation holds high potential in the realm of respiratory care, offering a sustainable alternative to conventional methods.

Learn More

Antimicrobial Transdermal Delivery: Reducing Infection Risks with Minimally Invasive Technology

Georgetown University researchers have developed a groundbreaking technology that addresses the critical need for mitigating adverse secondary effects from minimally invasive medical procedures, monitoring, and drug delivery devices.

Learn More

Upcoming Events

2024 Innovation Awards Ceremony – March 13, 2024

This event promises to be a remarkable celebration of the astounding achievements of our dedicated faculty and researchers as they continue to make profound contributions to society through their groundbreaking inventions.